AndJu, MB - company info and details

Company age: 2 y. 9 mo.

Update

Company overview

Company name AndJu, MB
Company code 306670149
VAT code LT100016821519
Registered address Vilnius, L. Giros g. 70-33, LT-06323
Registration date 2024-01-29 Company age: 2 y. 9 mo.
Phone Phone
Email Not disclosed (personal)
Website None
Company manager For registered members only Log in
Revenue (2025) 86,340 € History
Profit (2025) 7,042 € +368% History
Number of employees 0
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 35 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
AndJu, MB (company code 306670149) is an operational private small partnership registered on 29 January 2024. It is classified as a micro company in the national private non-financial companies sector and is owned under private ownership, where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is described as CEO only. The company is based in Vilnius, Vilniaus m. municipality, Vilniaus county, at L. Giros g. 70-33, LT-06323. Its registered activity under EVRK code G.47.73.00 is retail sale of pharmaceutical products. Financially, the company reported revenue of EUR 86.3 thousand in 2025, up strongly from EUR 3.6 thousand in 2024. Net profit for 2025 was EUR 7.0 thousand, compared with EUR 1.5 thousand a year earlier, while the profit margin decreased to 8.2% from 41.9% in 2024. At the end of 2025, equity stood at EUR 8.5 thousand, liabilities at EUR 456, and total assets at EUR 9.0 thousand. The balance sheet remained lightly leveraged, with equity representing most of the asset base.

Download a detailed company report

Make confident decisions with all the information about AndJu, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report